Veracyte Meets New Medicare Coverage Mandate For Molecular Dx

Veracyte announced a positive coverage policy from Palmetto GBA Jan. 9 for its Afirma multi-gene expression classifier test, one of the first to go through the Medicare contractor’s new requirements.